Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger CCHC domain-containing protein 24 (ZCCHC24) is a member of the zinc finger CCHC-type protein superfamily, defined by a consensus motif (Cys-X(2)-Cys-X(4)-His-X(4)-Cys) known for binding single-stranded nucleic acids, particularly RNA[1][3]. ZCCHC24 contains this zinc-knuckle domain and is predicted to function as an RNA-binding and zinc-binding protein[2]. While the ZCCHC superfamily broadly participates in RNA metabolism—including processes like transcription, biogenesis, splicing, translation, and degradation—there is currently little specific knowledge about the biological function or disease relevance of ZCCHC24 itself. It is not currently classified as a receptor, enzyme, or druggable target, nor is it associated with disease roles or studied as a biomarker[1][2][4].
Not applicable, as there are no approved or experimental drugs targeting this molecule directly[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger CCHC domain-containing protein 24 (ZCCHC24).